File S1 - Preclinical Validation of Talaporfin Sodium-Mediated Photodynamic Therapy for Esophageal Squamous Cell Carcinoma

Supporting data. Data S1, The fluorescence intensity of talaporfin sodium in cultured ESCC cells. (A) TE-5, (B) TE-8, (C) TE-10, (D) TE-11, (E) TE-5R, (F) TE-11R, Comp-APC-A: Compensated-Allophycocyanin (APC)-Area. Data S2, Cytotoxic effect of t-PDT on ESCC cells. The number of viable cells after t-PDT was expressed as a percentage of unirradiated control cells. (A) TE-5, (B) TE-8, (C) TE-10, (D) TE-11, (E) TE-5R, (F) TE-11R. Data S3, Flow cytometric analysis with Annexin V/Propidium iodide double-staining. Annexin V and Propidium iodide (PI) is detected by FITC and phycoerythrin (PE), respectively. Data S4, Xenograft tumor size. Each table represents the tumor volume (upper table) and the response rate (lower table).
(XLSX)